Table 2 The management and outcome of the relapse patients
Patients No | Relapse | Symptoms | Signs | Pretreatment hCG(IU/L) | Interval times after hCG negative (months) | Surgery | Pathological diagnosis | Treatment |
|---|---|---|---|---|---|---|---|---|
6 | 1 | None | Persistent right lung mass | 20.6 | 3 | VATS | CC with pulmonary metastasis | 3 cycles of EMA-CO |
8 | 1 | None | Left ovary abnormality | 180.9 | 5 + | LUSO | CC | 5 cycles of TP |
10 | 1 | Epilepsy, convulsions | Brain mass | 10.9 | 3 + | Gamma knife | CC with brain metastasis | Weekly Albumin Paclitaxel combined with PD-1 immunotherapy (Tirelizumab) for 5 cycles, Tirelizumab maintenance therapy |